Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin
Julio Rosenstock, Stephen C. Bain, Amoolya Gowda, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 4, pp. 297-308
Open Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

Once-Weekly Insulin Icodec With Dosing Guide App Versus Once-Daily Basal Insulin Analogues in Insulin-Naive Type 2 Diabetes (ONWARDS 5)
Harpreet S. Bajaj, Jens Aberle, Melanie J. Davies, et al.
Annals of Internal Medicine (2023) Vol. 176, Iss. 11, pp. 1476-1485
Closed Access | Times Cited: 50
The Basis for Weekly Insulin Therapy: Evolving Evidence With Insulin Icodec and Insulin Efsitora Alfa
Julio Rosenstock, Rattan Juneja, John M. Beals, et al.
Endocrine Reviews (2024) Vol. 45, Iss. 3, pp. 379-413
Open Access | Times Cited: 30
Recent advances in the treatment of type 2 diabetes mellitus using new drug therapies
Keong Chong, Jack. Keng-Jui Chang, Lee‐Ming Chuang
The Kaohsiung Journal of Medical Sciences (2024) Vol. 40, Iss. 3, pp. 212-220
Open Access | Times Cited: 18
Efficacy and safety of once‐weekly insulin icodec in type 2 diabetes: A meta‐analysis of ONWARDS phase 3 randomized controlled trials
Sahana Shetty, Renuka Suvarna
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 3, pp. 1069-1081
Open Access | Times Cited: 12
Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment
Carol Wysham, Harpreet S. Bajaj, Stefano Del Prato, et al.
New England Journal of Medicine (2024)
Closed Access | Times Cited: 11
Continuous Glucose Monitoring–Based Metrics and Hypoglycemia Duration in Insulin-Experienced Individuals With Long-standing Type 2 Diabetes Switched From a Daily Basal Insulin to Once-Weekly Insulin Icodec: Post Hoc Analysis of ONWARDS 2 and ONWARDS 4
Harpreet S. Bajaj, Björg Ásbjörnsdóttir, Lisbeth Carstensen, et al.
Diabetes Care (2024) Vol. 47, Iss. 4, pp. 729-738
Open Access | Times Cited: 10
Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes
Roberto Trevisan, Matteo Conti, Stefano Ciardullo
Diabetologia (2024) Vol. 67, Iss. 8, pp. 1480-1492
Open Access | Times Cited: 10
Current barriers to initiating insulin therapy in individuals with type 2 diabetes
Alba Galdón Sanz-Pastor, Alicia Justel Enríquez, Ana Sánchez Bao, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 9
Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial
Ildiko Lingvay, Malik Benamar, Liming Chen, et al.
Diabetologia (2025)
Open Access | Times Cited: 1
An overview of insulin therapy for the non‐specialist
Philip Home
Diabetes Obesity and Metabolism (2025)
Open Access | Times Cited: 1
Pharmacokinetic and pharmacodynamic properties of once‐weekly insulin icodec in individuals with type 2 diabetes
Thomas R. Pieber, Marisse Asong, Gabriele Fluhr, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 12, pp. 3716-3723
Open Access | Times Cited: 18
The Effect of Various Degrees of Renal or Hepatic Impairment on the Pharmacokinetic Properties of Once-Weekly Insulin Icodec
Hanne Haahr, Blanka Cieslarová, Janne R. Hingst, et al.
Clinical Pharmacokinetics (2024) Vol. 63, Iss. 6, pp. 819-830
Open Access | Times Cited: 8
Once‐weekly insulin icodec compared with daily basal insulin analogues in type 2 diabetes: Participant‐level meta‐analysis of the ONWARDS 1–5 trials
Harpreet S. Bajaj, Björg Ásbjörnsdóttir, Tanvir Johanning Bari, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 9, pp. 3810-3820
Open Access | Times Cited: 7
Efficacy and Safety of Once-Weekly Insulin Regimes on Glycemic Control for Type 2 Diabetes: A Systematic Review and Network Meta-analysis
Peng Wang, Yu Zhang, W. Xu, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Clinical Outcomes With Once‐Weekly Insulin Icodec Versus Once‐Daily Insulin Glargine U100 in Insulin‐Naïve and Previously Insulin‐Treated Individuals With Type 2 Diabetes: A Meta‐Analysis of Randomised Controlled Trials
Mushood Ahmed, Aimen Shafiq, Hira Javaid, et al.
Endocrinology Diabetes & Metabolism (2024) Vol. 7, Iss. 3
Open Access | Times Cited: 4
Understanding the Pharmacokinetics and Glucodynamics of Once Weekly Basal Insulins to Inform Dosing Principles: An Introduction to Clinicians
Thomas R. Pieber, Jennifer Leohr, Juliana Bue‐Valleskey, et al.
Endocrine Practice (2024) Vol. 30, Iss. 9, pp. 863-869
Open Access | Times Cited: 4
Insulin Icodec: First Approval
Hannah A. Blair
BioDrugs (2024) Vol. 38, Iss. 5, pp. 717-724
Closed Access | Times Cited: 4
The rise of weekly insulins: addressing the challenges of type 2 diabetes care in Brazil
André Gustavo Daher Vianna, Diana Alves, Taís Silveira Assmann, et al.
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access
Weekly injectable insulin icodec for adults with diabetes
Sooyoun Shin, Catherine Yu
Canadian Medical Association Journal (2025) Vol. 197, Iss. 2, pp. E44-E44
Open Access
Does Improvement of Glycemic Control Cause Acute Charcot Foot in Patients with Diabetes?
Ole Lander Svendsen, Rasmus Bo Jansen
Experimental and Clinical Endocrinology & Diabetes (2025)
Open Access
Perioperative and periprocedural management of once-weekly insulin treated patients
Robyn L. Houlden, Jeremy Gilbert, Tayyab Khan, et al.
Endocrine Practice (2025)
Closed Access
Once-Weekly Insulins
J. Hans DeVries, Tim Heise
Diabetes Technology & Therapeutics (2025)
Closed Access
Efficacy and hypoglycaemia outcomes with once‐weekly insulin icodec versus once‐daily basal insulin in individuals with type 2 diabetes by kidney function: A post hoc participant‐level analysis of the ONWARDS 1–5 trials
Peter Rossing, Malik Benamar, Alice Cheng, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Pharmacokinetic properties of once‐weekly insulin icodec in Chinese individuals with type 2 diabetes
Yijun Li, Ariel Fu, Shan Jiang, et al.
Journal of Diabetes Investigation (2025)
Open Access
Navigating Insulin Options for Diabetes Management
Ebne Rafi, Lily Tranchito, Betül Hatipoğlu
The Journal of Clinical Endocrinology & Metabolism (2025) Vol. 110, Iss. Supplement_2, pp. S159-S164
Closed Access
Page 1 - Next Page

Scroll to top